Etana Biotech Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
320

- Latest Deal Type
-
Later Stage VC
- Investors
-
8
Etana Biotech General Information
Description
Operator of a biotech company intended to manufacture biosimilars for Indonesia and other emerging countries. The company engages in the development and commercialization of biological drugs in the oncology field and other life-threatening diseases and in manufacturing, R&D, and marketing of recombinant gene technology, and monoclonal antibody drugs, providing patients with affordable medicines and vaccines.
Contact Information
Website
www.id.etanabiotech.comCorporate Office
- Kawasan Industri Pulogadung, Jl. Rawa Gelam V Blok L Kav
- 11-13, Jatinegara, Cakung
- East Jakarta, 13930
- Indonesia
Corporate Office
- Kawasan Industri Pulogadung, Jl. Rawa Gelam V Blok L Kav
- 11-13, Jatinegara, Cakung
- East Jakarta, 13930
- Indonesia
Etana Biotech Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC | 20-Mar-2023 | Completed | Generating Revenue | |||
2. Later Stage VC (Series B) | 28-Sep-2022 | Completed | Generating Revenue | |||
1. Later Stage VC (Series A) | 14-Sep-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Etana Biotech Comparisons
Industry
Financing
Details
Etana Biotech Competitors (71)
One of Etana Biotech’s 71 competitors is BeiGene, a Formerly PE-Backed company based in Beijing, China.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
BeiGene | Formerly PE-Backed | Beijing, China | ||||
Innovent Biologics | Formerly PE-Backed | Shanghai, China | ||||
Alphamab Oncology | Formerly VC-backed | Suzhou, China | ||||
Gyre Therapeutics | Formerly VC-backed | San Diego, CA | ||||
Brii Biosciences | Formerly VC-backed | Beijing, China |
Etana Biotech Signals
Etana Biotech Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
DEG | PE/Buyout | Minority | ||
East Ventures | Venture Capital | Minority | ||
China Medical System | Corporation | Minority | ||
Highlight Capital | Venture Capital | Minority | ||
Yunfeng Capital | PE/Buyout | Minority |
Etana Biotech FAQs
-
When was Etana Biotech founded?
Etana Biotech was founded in 2014.
-
Where is Etana Biotech headquartered?
Etana Biotech is headquartered in East Jakarta, Indonesia.
-
What is the size of Etana Biotech?
Etana Biotech has 320 total employees.
-
What industry is Etana Biotech in?
Etana Biotech’s primary industry is Biotechnology.
-
Is Etana Biotech a private or public company?
Etana Biotech is a Private company.
-
What is Etana Biotech’s current revenue?
The current revenue for Etana Biotech is
. -
Who are Etana Biotech’s investors?
DEG, East Ventures, China Medical System, Highlight Capital, and Yunfeng Capital are 5 of 8 investors who have invested in Etana Biotech.
-
Who are Etana Biotech’s competitors?
BeiGene, Innovent Biologics, Alphamab Oncology, Gyre Therapeutics, and Brii Biosciences are some of the 71 competitors of Etana Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »